Argentina vs Dominican Republic: Average cost of multi drug-resistant tuberculosis treatment
Argentina
1,547 constant 2022 US$
in 2024
Dominican Republic
1,650 constant 2022 US$
in 2024
Argentina rank
31st
Dominican Republic rank
28th
Average cost of multi drug-resistant tuberculosis treatment over time
- Argentina
- Dominican Republic
How they compare
Dominican Republic currently reports 1,650 constant 2022 US$ against 1,547 constant 2022 US$ in Argentina, a difference of 103 constant 2022 US$.
That makes Dominican Republic's figure about 1.1 times Argentina's.
The two have swapped places 1 time across 8 shared years of data; in 2017 it was Argentina ahead.
Argentina ranks 31st and Dominican Republic ranks 28th of 92 countries.
Across the 2 decades both report, Argentina averaged higher in 1 and Dominican Republic in 1.
Head to head by decade
| Decade | Argentina | Dominican Republic | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 3,035 constant 2022 US$ | 1,951 constant 2022 US$ | 1,084 constant 2022 US$ | Argentina |
| 2020s | 1,334 constant 2022 US$ | 1,859 constant 2022 US$ | 525 constant 2022 US$ | Dominican Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of multi drug-resistant tuberculosis treatment, Argentina or Dominican Republic?
- Dominican Republic, at 1,650 constant 2022 US$ against 1,547 constant 2022 US$ in Argentina as of 2024.
- What is the difference in average cost of multi drug-resistant tuberculosis treatment between Argentina and Dominican Republic?
- 103 constant 2022 US$, with Dominican Republic ahead.
- How many years of comparable data are there for Argentina and Dominican Republic?
- 8 years are reported by both, from 2017 to 2024.
- How do Argentina and Dominican Republic rank globally for average cost of multi drug-resistant tuberculosis treatment?
- Argentina ranks 31st and Dominican Republic ranks 28th of 92 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of multi drug-resistant tuberculosis treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per patient starting multidrug-resistant tuberculosis treatment, excluding buffer stock.